Revenue
$216.2m
+16.2% ↑ vs $186.1m
Revenue rose 16.2% and gross margin doubled to 23%, yet $6.3m working-capital absorption masked the underlying cash translation.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Key metrics
FY21 vs FY20
Revenue
$216.2m
+16.2% ↑ vs $186.1m
EBITDA
$22.1m
+289.9% ↑ vs −$11.6m
Net profit after tax
$9.6m
+155.5% ↑ vs −$17.3m
Net cash inflow from operating activities
$13.4m
-31.4% ↓ vs $19.6m
Full-year dividend per share
6.0c
↑ vs 0.0c
Profit before tax
$12m
+151.3% ↑ vs −$23.4m
Cash and cash equivalents
$12.2m
+58.1% ↑ vs $7.7m
Total assets
$194.5m
+0.7% ↑ vs $193.1m
What changed
Revenue grew 16.2% to $216.2m, gross margin expanded roughly 1,000bps to 23% (from 13%), and EBITDA reached $22.1m against an $11.6m EBITDA loss in FY20. NPAT recovered to $9.6m from a $17.3m loss, with PBT growth of 151.2% closely tracking NPAT growth of 155.5%.
Operating cash flow nonetheless fell 31.4% to $13.4m despite the EBITDA swing. Working capital absorbed $6.3m as operating working capital rose to $52.4m from $46.1m, mainly through a 17.3% lift in trade debtors to $27.5m.
The balance sheet strengthened: cash rose to $12.2m from $7.7m, and the group moved to a $1.3m net cash position from $3.4m net debt. A 4.0 cents final dividend takes full-year dividends to 6.0 cents per share, against nil in FY20.
What matters
Moving from 13% to 23% on a 16.2% larger revenue base is the central economic event of the result. EBITDA of $22.1m against a prior-year loss is largely a function of this margin reset rather than volume alone, which means the strategy is producing visible run-rate evidence rather than one-off recovery.
Cash conversion at 60.7% (OCF/EBITDA) sits well below the earnings recovery. For a project-based industrials business this matters because the gap is funded by a $6.3m working-capital absorption — mainly debtors — at a point when contract assets stand at $24.5m and contract liabilities at $22.7m. Accounting profit is being recognised faster than cash, which is consistent with a growth-phase project mix but warrants close tracking.
Australasia carried the result; Europe and North America de-weighted. Australasia revenue grew to $112.1m and now represents 51.8% of the group (from 38.4%), with a $17.5m segment result at a 15.7% gross margin. Europe shrank 19.9% to $54.0m at an 8.6% gross margin, the weakest segment, while North America fell to $37.2m. Group-level margin gains partially mask a sharper geographic story.
Expectations
Comparing HY21 ($104.5m revenue, $11.2m EBITDA, $4.7m NPAT) against the full year implies a second half of $111.7m revenue, $10.9m EBITDA and $4.9m NPAT — modestly second-half-weighted on revenue but slightly first-half-weighted on EBITDA, indicating a flatter project-delivery profile than typically seen in this sector.
Without a forward-work disclosure or stated FY22 target, the release supports continuity of the FY21 margin shape but does not evidence acceleration. The investor read is whether the gross margin holds once segment mix normalises.
Quality of result
PBT growth (151.2%) and NPAT growth (155.5%) are materially in line — the small -4.3pp gap reflects a -20.6% current effective tax rate (a net tax benefit) against 25.4% prior. PBT is therefore the cleaner operating read, and it confirms the turnaround rather than relying on tax. FCF (pre-lease) of $8.9m and a 92.6% FCF/NPAT ratio look constructive at first inspection.
The qualifier sits on cash. OCF/EBITDA at 60.7% reflects a $6.3m working-capital build, and the prior-year ratio is not analytically usable as a comparison anchor given the negative EBITDA denominator. For a project-based industrials business this is timing-sensitive: contract assets of $24.5m against contract liabilities of $22.7m point to a roughly balanced milestone position, so the receivables increase is the swing factor. The 4.0 cents final dividend is covered by FCF pre-lease at a 52.7% payout, so capital return is funded from cash, not balance-sheet capacity.
Unresolved
This briefing cannot assess management's FY22 trading outlook, contracted backlog composition, or the durability of the gross margin uplift, because no forward-work figures or FY22 targets are provided in the supplied release context.
Chat
Ask follow-up questions about Scott Technology's FY21 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
NZX Results Announcement
FY21 / results announcementScott 2021 Full Year Investor Presentation
FY21 / results presentationScott Announces FY21 Results
FY21 / results releaseScott Annual Report 2021
FY21 / financial reportNZX Results Announcement
FY20 / results announcementNZX Results Announcement
FY20 / results releaseScott Annual Report 2020
FY20 / financial report2021 Half Year Financial Statements
HY21 / financial report2021 Half Year Results Announcement
HY21 / results releasecompany filing
HY21 / results announcementRelated insights
Cross-company views selected from the metrics in this briefing.
Cash conversion quality
This result converted 60.7% of EBITDA to operating cash flow, +228.7pp versus the prior comparable period.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 4.3pp, with a distortion flag in the result.
ROE and capital efficiency
ROE was 9.8%, +28.5pp versus the prior comparable period.
Revenue growth context
Revenue growth was 16.2% for this reporting period.
Get the next Scott Technology briefing and related NZX reporting-season updates by email.